ENZY Enzymotec Ltd. - Ordinary Shares (delisted)

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of August 2016

 

Commission File Number: 001-36073

 

                   ENZYMOTEC LTD.                     
(Translation of registrant’s name into English)

 

Sagi 2000 Industrial Area
P.O. Box 6

 Migdal Ha’Emeq 2310001, Israel

 (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F  ☒     Form 40-F  ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   __

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   __

 

CONTENTS

On August 9, 2016, Enzymotec Ltd. (NASDAQ: ENZY) (the “ Company ”) announced its financial results for the second quarter and six months ended June 30, 2016.  A copy of the press release announcing the Company’s results is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K (“ Form 6-K ”) and is incorporated herein by reference.

  

The information in this Form 6-K, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.